Jens Kort

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial”.

One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial

Kidney International Reports(2021)10.1016/j.ekir.2021.11.022

N/A

0.834DataRank · unranked

20 citations

David S. Goldberg, Douglas E. Schaubel, Robert J. Fontana, Jens Kort, Rita R. Alloway +17 more

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C

Clinical Infectious Diseases(2025)10.1093/cid/ciaf305

N/A

0.104DataRank · unranked

1 citations

Min‐Hee Kang, Triin Umbleja, Estêvão Portela Nunes, Kristen Marks, Anne F. Luetkemeyer +67 more

Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection

Journal of the American Society of Nephrology(2020)10.1681/asn.2020050686

N/A

0DataRank · unranked

71 citations

David S. Goldberg, Jens Kort, Douglas E. Schaubel, Rita R. Alloway, Christine M. Durand +24 more